On July 28, 2026, Universal Health Services (UHS) disclosed a $50 million increase to its full-year professional and general liability reserve estimate during its Q2 earnings call. CFO Steve Filton was specific about the driver: “cases are just worth more in settlements.” He framed the adjustment as a response to industry-wide severity trends confirmed through the company’s semi-annual actuarial review, not to specific large losses at UHS facilities. The $28 million in-quarter charge was large enough to reduce UHS’s full-year EBITDA guidance by the same amount.
That framing matters. When a major hospital operator with dedicated actuarial resources attributes a mid-year reserve charge to industry conditions rather than a single catastrophic claim, it is confirming that the severity assumptions embedded in open case reserves and IBNR calculations have moved beneath them.
Who it affects
More than a dozen large U.S. health systems self-insure their malpractice exposure through owned captives. Many mid-sized systems retain large deductibles under excess malpractice programs and set their own initial case reserves. For those programs, the UHS disclosure is the clearest public balance-sheet signal yet that the severity baseline embedded in their reserve factors may be trailing current settlement values.
Nonprofit health systems do not publish quarterly earnings. The gap between what public operators are disclosing and the actual reserve posture of the broader hospital sector is almost certainly wider than the UHS figure alone suggests.
The reserve mechanism
The issue is case reserve adequacy, not claim frequency. Severity is doing the work. Indemnity payments across approximately 170 specialty malpractice carriers exceeded $2.9 billion in the first three quarters of 2025, up 17% on broadly flat claim frequency (CM&F Group). The average of the top 50 malpractice verdicts rose from approximately $32 million in 2022 to $56 million in 2024, a 75% increase in two years (Medical Economics). Verdicts exceeding $25 million more than tripled between the 2013-2015 window and 2022-2024. Payments of $500,000 or more represented 36.5% of all physician payments in 2024, a new record high (Risk & Insurance).
The commercial market registered $259 million in adverse prior-year reserve development on claims-made business in 2025, with Curi Holdings ($129 million), Liberty Mutual ($128 million), and Farmers ($94 million) each booking material adverse development.
For a self-insured health system, this translates into two specific exposures. First, initial case reserves on major open claims from 2023 and 2024 were likely set using severity benchmarks that are already below current settlement values. Second, the IBNR tail factor for professional liability, which must capture the three-to-five year reporting lag on catastrophic birth injury, surgical error, and cancer-misdiagnosis claims, needs a severity trend assumption that reflects today’s verdict environment, not a 2021-2022 baseline.
A chain-ladder model applied without adjustment for the shift in case reserve adequacy will misread the development pattern and understate IBNR. See the hospital professional liability IBNR guide for how tail factors are constructed in this line, and the case reserve strengthening explainer for how inadequate initial reserves distort the triangle.
Where this shows up in your reserves
On the actuarial report, look at the professional liability development triangle for accident years 2022 through 2025. If paid-to-incurred ratios are rising faster than historical development patterns predicted, and if case reserve strengthening is concentrated in claims that have been open two years or more, that is the signal. On Schedule P (for captives filing with a domicile regulator), look at the incurred-but-not-reported line relative to prior-year estimates for the same accident years.
What this means for your next review
Three questions for your actuary before the next reserve study closes:
- Are open case reserves for 2023 and 2024 malpractice claims being evaluated against current verdict benchmarks, or are they still carrying the factors established when those claims were first opened?
- What severity trend assumption is embedded in the IBNR tail factors, and when was it last updated against current settlement data?
- Given that the average top-50 verdict grew 75% in two years, has the expected loss per claim been restated in the current actuarial opinion?
If your health system carries malpractice exposure through a captive, the reserve adequacy question extends to the captive’s balance sheet and the collateral or capital supporting it. The single-parent captive IBNR guide covers how these structures absorb professional liability tail.
From tracking mid-year reserve disclosures across public hospital operators over eight consecutive reporting quarters, the pattern of attributing mid-year strengthening to industry-wide severity rather than to specific large claims is new in 2026. Prior-year mid-year charges were driven by individual large losses; the 2026 UHS language points to a more systemic repricing of the malpractice tail.
Watch Q3: if a second consecutive quarter of mid-year reserve strengthening appears in hospital operator disclosures this fall, it will confirm that the severity reset is ongoing rather than a one-time recalibration.
An independent reserve review brings a second pair of eyes free of the TPA’s or fronting carrier’s incentive structure. We are working on a directory of independent reviewing actuaries. If you would like to be considered, get in touch.
Sources
- Universal Health Services Q2 2026 Earnings Call Summary, July 28, 2026
- UHS Q2 FY2026 Earnings Call, BigGo Finance
- Medical Malpractice Claim Severity Escalating, Risk & Insurance
- Nuclear Verdicts Resetting Malpractice Case Values, Medical Economics
- Why Medical Malpractice Claims Cost More Than Ever, KevinMD, July 2026
- CM&F Group: 2026 Malpractice Claims Data and Healthcare Liability Landscape